PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 10442631)

Published in Oncogene on August 05, 1999

Authors

G Condorelli1, G Vigliotta, A Cafieri, A Trencia, P Andalò, F Oriente, C Miele, M Caruso, P Formisano, F Beguinot

Author Affiliations

1: Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, Federico II University of Naples Medical School, Italy.

Articles citing this

The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. Biochem J (2003) 2.25

Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol (2003) 1.67

Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci U S A (2008) 1.52

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A (2012) 1.52

A Shope Fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes (2007) 1.41

Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J (2002) 1.40

Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell (2005) 1.33

Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J (2005) 1.24

Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation. Infect Immun (2006) 1.23

Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell (2000) 1.22

PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J Cell Mol Med (2008) 0.99

Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15. Mol Biol Cell (2006) 0.98

PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res (2008) 0.98

Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol (2004) 0.98

Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion. Recent Pat Anticancer Drug Discov (2011) 0.97

The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes. Diabetologia (2006) 0.93

Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance. J Biol Chem (2014) 0.91

Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell (2006) 0.90

PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15. Mol Cell Biol (2008) 0.90

The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment. Biomed Res Int (2014) 0.89

The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. FASEB J (2010) 0.88

Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. J Biol Chem (2008) 0.87

The PYRIN domain in signal transduction. Curr Protein Pept Sci (2007) 0.85

PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer (2012) 0.85

PED/PEA-15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis. J Cell Mol Med (2012) 0.83

Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells. J Cell Physiol (2014) 0.83

Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha. Mol Biol Cell (2009) 0.81

Quantitative proteomics for identifying biomarkers for Rabies. Clin Proteomics (2013) 0.81

Human cytomegalovirus manipulation of latently infected cells. Viruses (2013) 0.81

Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate (2010) 0.80

Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma. Cell Death Differ (2015) 0.79

Vanishin is a novel ubiquitinylated death-effector domain protein that blocks ERK activation. Biochem J (2005) 0.79

Estradiol attenuates down-regulation of PEA-15 and its two phosphorylated forms in ischemic brain injury. Lab Anim Res (2015) 0.77

Monomeric and dimeric models of ERK2 in conjunction with studies on cellular localization, nuclear translocation, and in vitro analysis. Mol Cells (2012) 0.77

Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther (2014) 0.76

Vitamin D3 signalling in the brain enhances the function of phosphoprotein enriched in astrocytes--15 kD (PEA-15). J Cell Mol Med (2009) 0.76

P45 forms a complex with FADD and promotes neuronal cell survival following spinal cord injury. PLoS One (2013) 0.76

PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1. PLoS One (2014) 0.75

On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities. Pharmaceuticals (Basel) (2015) 0.75

Hyperglycemia aggravates decreases of PEA-15 and its two phosphorylated forms in cerebral ischemia. J Vet Med Sci (2017) 0.75

Chaperone-mediated autophagy substrate proteins in cancer. Oncotarget (2017) 0.75

Articles by these authors

Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem (1996) 3.05

Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol (2000) 1.71

Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res (2001) 1.70

Function of yeast species and strains in wine flavour. Int J Food Microbiol (2003) 1.64

Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes (1989) 1.55

PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J (1998) 1.47

Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. Infect Immun (2008) 1.39

Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem (1998) 1.38

Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol (1999) 1.35

Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem (1985) 1.33

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol (2001) 1.32

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. Ann Oncol (2007) 1.28

Patient education model for increasing handwashing compliance. Am J Infect Control (1999) 1.27

Host--virus interactions in the control of T4 prereplicative transcription. II. Interaction between tabC (rho) mutants and T4 mot mutants. J Mol Biol (1979) 1.25

MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene (1994) 1.20

Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis (2006) 1.18

Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut (2008) 1.12

[Total laparoscopic hysterectomy versus vaginal hysterectomy: a prospective randomized trial]. Minerva Ginecol (2007) 1.11

Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes (2001) 1.09

Activation and mitochondrial translocation of protein kinase Cdelta are necessary for insulin stimulation of pyruvate dehydrogenase complex activity in muscle and liver cells. J Biol Chem (2001) 1.07

A variety of RNA polymerases II and III-dependent promoter classes is repressed by factors containing the Krüppel-associated/finger preceding box of zinc finger proteins. Gene (1999) 1.06

Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem (1995) 1.06

Growth-promoting action and growth factor release by different platelet derivatives. Platelets (2013) 1.05

Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg (1994) 1.05

Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04

Long-term results with the titanium bone-anchored hearing aid: the U.S. experience. Am J Otol (1998) 1.04

Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia (2012) 1.03

Interactions of Tn7 and temperate phage F116L of Pseudomonas aeruginosa. Mol Gen Genet (1982) 1.03

Review: Preclinical studies on placenta-derived cells and amniotic membrane: an update. Placenta (2011) 1.02

Targeted gene transfer in eucaryotic cells by dye-assisted laser optoporation. J Photochem Photobiol B (1996) 1.02

Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia (2011) 0.99

Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry (1995) 0.98

Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Nucleic Acids Res (1999) 0.96

A survey of the enterococci isolated from an artisanal Italian goat's cheese (semicotto caprino). J Appl Microbiol (2000) 0.96

Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to beta-amyloid. Neurobiol Aging (2005) 0.96

Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action. J Biol Chem (1993) 0.96

In skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. J Biol Chem (1997) 0.95

Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia (2010) 0.95

Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol Cell Biol (2000) 0.94

A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes (1994) 0.94

Mouse genes coding for "zinc-finger"-containing proteins: characterization and expression in differentiated cells. Proc Natl Acad Sci U S A (1989) 0.94

[Laparoscopic lymphadenectomy as treatment of endometrial cancer]. Minerva Ginecol (2007) 0.94

Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats. Transplant Proc (2008) 0.94

Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology (2004) 0.94

The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes. Diabetologia (2006) 0.93

Role of phospholipids in the structure and function of the thyrotropin receptor. J Biol Chem (1979) 0.93

Host--virus interactions in the control of T4 prereplicative transcription. I. tabC (rho) mutants. J Mol Biol (1979) 0.93

The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J Virol (1995) 0.93

Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat. Gut (2007) 0.92

Tetanus toxin and thyrotropin interactions with rat brain membrane preparations. J Biol Chem (1979) 0.92

In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routing. J Biol Chem (1998) 0.92

Experimental analyses of gene-brain-behavior relations: some notes on their application. J Appl Behav Anal (2001) 0.92

A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice. Mol Cell Biol (1995) 0.91

Perspectives for genetic engineering of hydrocarbon oxidizing bacteria. Basic Life Sci (1981) 0.91

Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patients from Sicily. Eur J Immunogenet (2004) 0.90

Vasospastic angina and scombroid syndrome: a case report. Acta Clin Belg (2012) 0.90

Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43. Cancer Gene Ther (2008) 0.89

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study. Ann Oncol (2007) 0.89

Sites hypersensitive to, and protected from, nuclease digestion in the regulatory region of wild-type and mutant polyoma chromatin. EMBO J (1986) 0.89

Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia (2011) 0.88

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score. Ann Oncol (2008) 0.88

The development of insulin receptors and responsiveness is an early marker of differentiation in the muscle cell line L6. Endocrinology (1986) 0.88